HEALTHCARE PROFESSIONALS

News

May 10, 2017 Additional Data Analysis From an IBS (Irritable Bowel Syndrome) Clinical Trial Demonstrate IBgard® Delivered Unprecedented Symptom Reduction in the Largest and Most Dissatisfied Group of IBS Patients

Read More

April 5, 2017 New Medical Research Shows Vitamin D Deficiency Observed in Children, Adolescents and Adults With Irritable Bowel Syndrome (IBS), Calling Attention to Managing Nutritional Requirements Related to IBS

Read More

February 23, 2017 Leading Gastroenterologists Agree That Diagnosing and Managing Irritable Bowel Syndrome (IBS) in Patients With IBS-M (Mixed Diarrhea and Constipation) Remains a Challenging and Difficult to Treat Medical Condition

Read More

December 19, 2016 Real-world Data From Surveillance Study Confirms Excellent Safety and Tolerability Profile of IBgard® at Twelve Months

Read More

December 14, 2016 For Second Consecutive Year, U.S. Gastroenterologists Endorse IBgard® as the #1 Recommended Peppermint Oil for IBS... By Overwhelming Margin

Read More

October 26, 2016 IBgard® Brings Symptom Relief to Millions of Canadians Suffering From Irritable Bowel Syndrome (IBS)

Read More

October 17, 2016 Final Results of Real-world Data From Surveillance Study Confirm High Levels of Patient Satisfaction and Rapid Irritable Bowel Syndrome (IBS) Symptom Improvement With Non-prescription IBgard®

Read More

September 27, 2016 Continuing Developments in Medical Consensus on the Utility of Peppermint Oil for Irritable Bowel Syndrome (IBS)

Read More

August 29, 2016 New Real-world Data From Surveillance Study Confirms Excellent Safety and Tolerability Profile of IBgard®

Read More

Access to this section is intended for Healthcare Practitioners only.

Please confirm below that you are a Healthcare Practitioner or click here to return to the consumer section of the site.

Confirm